首页> 外文期刊>Transplant immunology >Mannose-binding lectin-2 and ficolin-2 gene polymorphisms and clinical risk factors for acute rejection in kidney transplantationXIaoxia Wu, Qiquan Wan , Qifa Ye , Jiandang Zhou
【24h】

Mannose-binding lectin-2 and ficolin-2 gene polymorphisms and clinical risk factors for acute rejection in kidney transplantationXIaoxia Wu, Qiquan Wan , Qifa Ye , Jiandang Zhou

机译:甘露糖结合型lectin-2和ficolin-2基因多态性与肾移植急性排斥反应的临床危险因素吴晓霞,万启全,叶启发,周建党

获取原文
获取原文并翻译 | 示例
           

摘要

Introduction: There is growing evidence that the lectin pathway is significantly associated with acute rejection. Rare studies associated both gene polymorphisms of MBL2 and FCN2 with acute rejection after kidney transplantation. The aim of the present study was to investigate the role of the lectin gene profile and clinical risk factors such as PRA level on acute rejection in kidney transplant recipients.Methods: We prospectively analyzed 157 kidney transplant recipients with and without acute rejection. A total of 6 well-known functional single-nucleotide polymorphisms in the MBL2 gene and 5 in the FCN2 gene of the recipients were determined by gene sequencing. MBL2 and FCN2 genotypic variants were analyzed for association with the incidence of acute rejection within the first year after kidney transplantation. Results: After adjusting for variables of P< 0.2, we found the differences in the incidence of acute rejection were only accordingto panel-reactive antibodies (odds ratios (OR) = 6.468,95% confidence intervals (CI) = 2.017-20.740, P = 0.002) and the HH genotypes of MBL2 promoter -550 (OR = 2.448, 95%CI = 1.026-5.839, P = 0.044). Conclusion: Panel-reactive antibodies and the HH genotypes of MBL2 promoter - 550 have significant impacts on the risk of developing acute rejection after kidney transplantation.
机译:简介:越来越多的证据表明,凝集素途径与急性排斥反应显着相关。罕见的研究表明,MBL2和FCN2的基因多态性与肾脏移植后的急性排斥反应有关。本研究的目的是研究凝集素基因谱和PRA水平等临床危险因素对肾移植受者急性排斥反应的作用。方法:我们前瞻性分析了157位有或没有急性排斥反应的肾移植受者。通过基因测序确定了受体的MBL2基因中共有6种众所周知的功能性单核苷酸多态性,而FCN2基因中共有5种已知的功能性单核苷酸多态性。分析MBL2和FCN2基因型变异与肾脏移植后第一年内急性排斥反应的发生率相关。结果:校正P <0.2的变量后,我们发现急性排斥反应的发生率仅根据小组反应性抗体而不同(几率(OR)= 6.468,95%置信区间(CI)= 2.017-20.740,P = 0.002)和MBL2启动子的HH基因型-550(OR = 2.448,95%CI = 1.026-5.839,P = 0.044)。结论:小组反应性抗体和MBL2启动子550的HH基因型对肾移植后发生急性排斥反应的风险有重大影响。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号